Valo Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $20M

  • Investors
  • 9

Valo Therapeutics General Information

Description

Developer of immunotherapy treatments designed to improve cancer treatment and prevention. The company develops a peptide-based immunotherapy platform that combines oncolytic and non-replicating viral vectors with disease-specific peptides to stimulate targeted immune responses, enabling the development of adaptable cancer therapies with improved specificity and immunogenicity.

Contact Information

Website
www.valotx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Viikinkaari 6
  • 00790 Helsinki
  • Finland
+358
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Viikinkaari 6
  • 00790 Helsinki
  • Finland
+358

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 10-Mar-2025 $20M Completed Clinical Trials - Phase 2
7. Later Stage VC 15-Nov-2021 Completed Clinical Trials - Phase 1
6. Later Stage VC 05-Mar-2021 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 06-Feb-2020 Cancelled Pre-Clinical Trials
4. Early Stage VC 06-Feb-2020 Completed Pre-Clinical Trials
3. Debt - General 04-Jul-2017 Completed Pre-Clinical Trials
2. Seed Round 31-Jan-2017 $4.91M $4.91M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2016 Completed Startup
To view Valo Therapeutics’s complete valuation and funding history, request access »

Valo Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Valo Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Valo Therapeutics Patents

Valo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202407048-D0 Cancer therapy Inactive 17-May-2024
JP-2023543554-A Modified mycobacterium bovis vaccine Active 03-Sep-2020
JP-7924955-B2 Modified mycobacterium bovis vaccine Active 03-Sep-2020
AU-2021336066-A1 Modified mycobacterium bovis vaccines Active 03-Sep-2020
AU-2021336066-B2 Modified mycobacterium bovis vaccines Active 03-Sep-2020 A61P35/00
To view Valo Therapeutics’s complete patent history, request access »

Valo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valo Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDP Venture Capital (Rome) Venture Capital Minority
Indaco Venture Partners Venture Capital Minority
Tech and Biomedical Foundation Venture Capital Minority
UNDERWOOD CAPITAL Asset Manager Minority
Angel (individual) Minority
You’re viewing 5 of 9 investors. Get the full list »

Valo Therapeutics FAQs

  • When was Valo Therapeutics founded?

    Valo Therapeutics was founded in 2016.

  • Where is Valo Therapeutics headquartered?

    Valo Therapeutics is headquartered in Helsinki, Finland.

  • What is the size of Valo Therapeutics?

    Valo Therapeutics has 16 total employees.

  • What industry is Valo Therapeutics in?

    Valo Therapeutics’s primary industry is Drug Discovery.

  • Is Valo Therapeutics a private or public company?

    Valo Therapeutics is a Private company.

  • What is Valo Therapeutics’s current revenue?

    The current revenue for Valo Therapeutics is .

  • How much funding has Valo Therapeutics raised over time?

    Valo Therapeutics has raised $44.7M.

  • Who are Valo Therapeutics’s investors?

    CDP Venture Capital (Rome), Indaco Venture Partners, Tech and Biomedical Foundation, UNDERWOOD CAPITAL, and are 5 of 9 investors who have invested in Valo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process